(Date:5/16/2008)...cs want agency to act, not wait years , ,...sumer drug ads on television should include a toll...eport adverse side effects, U.S. health experts su...that advises the U.S. Food and Drug Administration...DA for print ads. At Friday,s meeting, the panel d...
(Date:5/16/2008)...SHINGTON, May 16 /PRNewswire-USNewswire/ -- More t...ns in the Greater Portland, Oregon and,Vancouver, ...tract as,Teamsters., "The Teamsters are pleased t...ract that gives them job protection and a secure r...t Jim Hoffa., The workers, both full-time and par...
(Date:5/16/2008)...efit from calcitriol, an oral form , , F... vitamin D may cut the risk of death for people wi...out one quarter, a new study suggests. , Durin...ose being treated with calcitriol, an oral form of...ath lowered by 26 percent when compared with those...
(Date:5/16/2008)...swire/- "Huh, what did you,say?" is a phrase being...ildren. More than 30 million Americans, that is 1 ...d the numbers are growing at a dramatic rate.,Thir...e form of hearing,loss. An effort to bring more at...t led Kathlyn Maguire, who has profound hearing lo...
Breaking Medicine News(10 mins):Health News:FDA Panel Considers Toll-Free Number for TV Drug Ads 2Health News:FDA Panel Considers Toll-Free Number for TV Drug Ads 3Health News:Vitamin D Use Linked to Lower Mortality in Kidney Patients 2Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 2Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 3(Date:5/15/2008)...H, N.J., May 15 /- Schering...ancing the science and treatment of,chronic hepati...data from,several clinical studies with PEGINTRON(...rin, USP) combination therapy, as well as boceprev...e inhibitor, will be presented at,the 39th annual ...
(Date:5/15/2008)...results obtained with a newly cleared device to id...f interest that are associated with ...N, Mass., May 15 /- InfraReDx, Inc. t...l in Royal Oak, Mich., have,successfully used its ...undergoing a cardiac catheterization. This is the ...
(Date:5/15/2008)...ay 15 /- CenterWatch, a publishing an...esearch about clinical,trials, finds that investig...ectronic data capture) systems. More than 75% of r...d that they had been trained on three or more,EDC ...e effectiveness of,their EDC training had improved...
(Date:5/15/2008)...Opportunity Remains for an Antiplatelet Therapy th...han the Combination of Plavix/Iscover and Aspi...rces, WALTHAM, Mass., May 15 /- Deci...h and advisory firms for pharmaceutical and,health... Effient offers,improvement in patient compared to...
Breaking Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3AutoImmune Inc Reports 2008 First Quarter Financial Results 18952 1AutoImmune Inc Reports 2008 First Quarter Financial Results 18952 2AutoImmune Inc Reports 2008 First Quarter Financial Results 18952 3Web Site Helps Patients Prepare for Hospital Stay 18948 1Web Site Helps Patients Prepare for Hospital Stay 18948 2Web Site Helps Patients Prepare for Hospital Stay 18948 3Development of new techniques to understand marble quality and durability 3248 1Development of new techniques to understand marble quality and durability 3248 2CIGNA HealthCare of Arizona and Catholic Healthcare West Reach Agreement 18944 1CIGNA HealthCare of Arizona and Catholic Healthcare West Reach Agreement 18944 2...IRE)--Jun 18, 2007 - Salix,Pharmaceuticals, Ltd. (...tion and outcome of its Phase III registration tri...00 mg tablet,formulation of balsalazide disodium (...active ingredient in COLAZAL(R),Capsules 750 mg, a... the treatment of mildly to moderately active ulce...
...07-Active Biotech (OMX Nordic: ACTI),has presented...h,World Congress on Inflammation (<a target="_blan...lammation2007.dk ) held,in Copenhagen June 16-20*....velopment of,57-57 for the treatment of SLE and sh...Phase II clinical trials are planned to be,initiat...
Other Medicine Technology:Salix Pharmaceuticals Announces Positive Top Line Results of,Balsalazide Tablets Registration Study 2Salix Pharmaceuticals Announces Positive Top Line Results of,Balsalazide Tablets Registration Study 3Active Biotech presents new pre-clinical data for the 57-57 project,at the 8th World Congress on Inflammation 2Single piece PMMA lens, AC depth: 4.9, 2 suture holes.
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia.
Hydrophilic Acrylic Intraocular Lens (Refractive and Bifocal). Anterior Chamber Lens.
...view™ hydrophilic acrylic IOL is the newest ...with the patient and surgeon in mind. Its unique o...cally crosslinked with PMMA haptics to provide sup...formance and biocompatibility. The high memory lat...
Medicine Products: